Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Why BPC-157 is the headliner (and why scientists keep asking the same questions) BPC-157 is a 15amino acid peptide that has lived two lives: one in a long-running research program centered in Croatia, and another as a gray-market product marketed for everything from tendon injuries to gut repair. A recent longform investigation co-published by STAT and Undark traced the peptides origin story to a decades-long project led by Predrag Sikiric at the University of Zagreb a project that produced lots of animal and cell studies, but far less in the way of modern, reproducible human clinical data (STAT)
Its often more cost-effective when doing long-term trials
This medication is prepared in a single-dose vial and contains 0.5% ropivacaine hydrochlorid
All treated 143B cells were subsequently analyzed using CLSM
